NCT02425748View on ClinicalTrials.gov

Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 8, 2017

Primary Completion Date

December 20, 2017

Study Completion Date

June 20, 2019

Conditions
Lung Cancer
Interventions
BIOLOGICAL

DC-CIK

DC-CIK cells will be used against tumor cells.

BIOLOGICAL

γδ T Cell

γδ T cells will be used against non small lung tumor.

BIOLOGICAL

γδ T/DC-CIK cells

γδ T/DC-CIK cells will be used against lung tumor.

Trial Locations (1)

510000

Biological treatment center in Fuda cancer hospital, Guangzhou

All Listed Sponsors
collaborator

Jinan University Guangzhou

OTHER

lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02425748 - Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation) | Biotech Hunter | Biotech Hunter